FDA approves first agent for treating autism symptoms: risperidone approval called ‘breakthrough.’.(Food and Drug Administration): An article from: Clinical Psychiatry News

This digital document is an article from Clinical Psychiatry News, published by Thomson Gale on November 1, 2006. The length of the article is 806 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: FDA approves first agent for treating autism symptoms: risperidone approval called ‘breakt

List Price: $ 9.95

Price: $ 9.95

Tagged with:

Filed under: Autism Symptoms

Like this post? Subscribe to my RSS feed and get loads more!